BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 46027)

  • 21. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.
    Arsenakis M; May JT
    Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.
    Braun RW; Teute HK; Kirchner H; Munk K
    J Immunol; 1984 Feb; 132(2):914-9. PubMed ID: 6317753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuraminidase reversal of resistance to lysis of herpes simplex virus-infected cells by antibody and complement.
    Tompkins WA; Seth P; Gee S; Rawls WE
    J Immunol; 1976 Feb; 116(2):489-95. PubMed ID: 175118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
    Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
    Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in antigenic properties of Fc-binding activity during infection with herpes simplex virus type 1.
    Welling-Wester S; Vos J; Wilterdink JB
    Arch Virol; 1984; 80(2-3):183-93. PubMed ID: 6202279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of antibodies to Herpes simplex virus types 1 and 2 by complement-dependent antibody lysis of infected cells.
    McClung H; Seth P; Rawls WE
    Am J Epidemiol; 1976 Aug; 104(2):181-91. PubMed ID: 60057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.
    Russell AS; Percy JS; Kovithavongs T
    Infect Immun; 1975 Feb; 11(2):355-9. PubMed ID: 163220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection.
    Kazmierowski JA; Peizner DS; Wuepper KD
    JAMA; 1982 May; 247(18):2547-50. PubMed ID: 6279897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rheumatoid factor and anti-immunoglobulin G antibodies on complement-mediated lysis of herpes simplex virus-infected human fibroblasts.
    Shivers JC; Daniels CA
    Infect Immun; 1977 Feb; 15(2):478-84. PubMed ID: 191401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Herpes simplex virus and glomerulonephritis].
    Filimonova RG; Nevraeva EG; Posevaia TA
    Ter Arkh; 1988; 60(6):88-91. PubMed ID: 2849813
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of concanavalin A with herpes simplex virus infected cells.
    Adler R; Paquette CI
    Can J Microbiol; 1980 Apr; 26(4):559-62. PubMed ID: 6247049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG subclass antibodies to herpes simplex virus.
    Coleman RM; Nahmias AJ; Williams SC; Phillips DJ; Black CM; Reimer CB
    J Infect Dis; 1985 May; 151(5):929-36. PubMed ID: 2985712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of the Fc receptor induced by herpes simplex virus.
    Costa J; Yee C; Nakamura Y; Rabson A
    Intervirology; 1978; 10(1):32-9. PubMed ID: 75867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of herpes simplex virus growth caused by preparations of animal immunoglobulins is not dependent on Fc-Fc receptor interactions.
    Johansson PJ; Kjellén L
    Intervirology; 1988; 29(6):334-8. PubMed ID: 2466016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes simplex virus specific antibody determined by immunoblotting in cerebrospinal fluid of a patient with the Guillain-Barré syndrome.
    Bernsen HJ; Van Loon AM; Poels RF; Verhagen WI; Frenken CW
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):788-91. PubMed ID: 2545828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of herpes simplex virus type 1-induced Fc receptor in its interaction with rabbit immunoglobulin G (IgG).
    Johansson PJ; Blomberg J
    APMIS; 1990 Aug; 98(8):685-94. PubMed ID: 2169770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
    Van Kessel KP; Van Kats-Renaud HJ; Van Strijp JA; Visser MR; Verhoef J
    J Immunol Methods; 1986 Apr; 88(1):101-7. PubMed ID: 3007623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.